Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (1,734) Arrow Down
Filter Results: (1,734) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (1,734)
    • People  (5)
    • News  (459)
    • Research  (916)
    • Events  (10)
    • Multimedia  (12)
  • Faculty Publications  (462)

Show Results For

  • All HBS Web  (1,734)
    • People  (5)
    • News  (459)
    • Research  (916)
    • Events  (10)
    • Multimedia  (12)
  • Faculty Publications  (462)
← Page 19 of 1,734 Results →
  • 01 Apr 2020
  • News

The Varying International Responses to Covid-19, and the U.S. Stimulus Package

  • December 2017
  • Case

Charity or Bribery?

By: Eugene Soltes and Brian Tilley
Filip Kowalski, a senior manager at the pharmaceutical company Healthgen, leads sales for the firm’s Polish division. While pitching Healthgen’s products, he develops a relationship with a director of a regional health fund who also runs a private foundation. After a... View Details
Keywords: Bribery; Crime and Corruption; Law; Ethics; Philanthropy and Charitable Giving; United States; Europe
Citation
Educators
Purchase
Related
Soltes, Eugene, and Brian Tilley. "Charity or Bribery?" Harvard Business School Case 118-052, December 2017.
  • 01 Jan 2004
  • News

  • 15 Sep 2016
  • News

Report: US government inaction is hampering economic growth

  • Video

Dr. Silvia Gold

Dr. Silvia Gold, President of the Mundo Sano Foundation and co-founder of Grupo Insud, outlines her company’s experience with prior public health crises such as the H1N1 outbreak, which allowed them to rapidly license and start producing materials for the AstraZeneca... View Details
  • January 2023
  • Case

Natura: Weathering the Pandemic at Brazil's Cosmetic Giant

By: Brian Trelstad, Pedro Levindo and Carla Larangeira
Brazil's Natura, a multi-brand cosmetics group, has taken several measures to safeguard the livelihoods of its thousands of employees and millions of sales representatives during the COVID-19 health and economic crisis. The company has also made strides in its efforts... View Details
Keywords: COVID-19 Pandemic; ESG Reporting; Acquisition; Customer Focus and Relationships; Decision Making; Social Entrepreneurship; Environmental Sustainability; Environmental Management; Climate Change; Ethics; Moral Sensibility; Values and Beliefs; Global Strategy; Corporate Governance; Health Pandemics; Human Resources; Human Capital; Crisis Management; Growth and Development Strategy; Marketing; Distribution Channels; Supply Chain; Corporate Social Responsibility and Impact; Mission and Purpose; Organizational Culture; Customer Ownership; Relationships; Business and Community Relations; Business and Stakeholder Relations; Networks; Partners and Partnerships; Science-Based Business; Reputation; Human Needs; Social Issues; Strategy; Equality and Inequality; Beauty and Cosmetics Industry; Brazil; Latin America
Citation
Educators
Related
Trelstad, Brian, Pedro Levindo, and Carla Larangeira. "Natura: Weathering the Pandemic at Brazil's Cosmetic Giant." Harvard Business School Case 323-065, January 2023.
  • 11 Jun 2019
  • Working Paper Summaries

Throwing the Baby Out with the Drinking Water: Unintended Consequences of Arsenic Mitigation Efforts in Bangladesh

Keywords: by Nina Buchmann, Erica Field, Rachel Glennerster, and Reshmaan Hussam
  • 28 Apr 2020
  • News

American economy on the bubble

  • June 2010 (Revised December 2010)
  • Case

Hôpital de Pontoise

By: Richard M.J. Bohmer, Daniela Beyersdorfer and Simon Harrow
In 2010, Andre Razafindranaly, managing director of a large French public hospital, considers which organizational structure will help them adjust to the changing health sector environment. The move from global budget to activity-based funding has led his and many... View Details
Keywords: Activity Based Costing and Management; Governance Controls; Governing Rules, Regulations, and Reforms; Health Care and Treatment; Leading Change; Service Delivery; Organizational Change and Adaptation; Organizational Structure; Health Industry; France
Citation
Find at Harvard
Related
Bohmer, Richard M.J., Daniela Beyersdorfer, and Simon Harrow. "Hôpital de Pontoise." Harvard Business School Case 610-100, June 2010. (Revised December 2010.)
  • 31 Jul 2018
  • First Look

New Research and Ideas, July 31, 2018

Shankar MD, Suptendra N. Sarbadhikari PhD, Barbara Bierer, Kenneth D. Mandl MD, Sanjay Mehendale MD, MPH, and Tarun Khanna Abstract—In February 2018, the Government of India announced a massive public health... View Details
Keywords: Dina Gerdeman

    Healthy Buildings: What Will We Measure and How Will We Know?

    Three irreversible trends -- realization of the deep downside of bad public health and bad buildings; the access to and democratization of air quality data; and the relaxation of the need to be present in-person, face-to-face, day-to-day -- will forever change... View Details
    • 2016
    • Working Paper

    Immigrant Entrepreneurs and the Social Safety Net

    By: Gareth Olds
    This paper explores the role of public health insurance in small business ownership among immigrants, a group with high rates of entrepreneurship. The Personal Responsibility and Work Opportunity Reconciliation Act of 1996 created a five-year “waiting period” for legal... View Details
    Keywords: Insurance; Entrepreneurship; Welfare or Wellbeing; Immigration
    Citation
    Read Now
    Related
    Olds, Gareth. "Immigrant Entrepreneurs and the Social Safety Net." Harvard Business School Working Paper, No. 16-142, June 2016.
    • March 2018 (Revised January 2019)
    • Case

    Gilead Mexico

    By: Michael Chu and V. Kasturi Rangan
    With a breakthrough cure for Hepatitis C listing in the U.S. at $1,000/pill, Gilead must now solve the issue of making it available to patients across the world, much as it did for its blockbuster HIV/AIDS antiretrovirals. For Erik Musalem, the new general manager of... View Details
    Keywords: Health Care and Treatment; Price; Strategy; Management; Pharmaceutical Industry; Mexico
    Citation
    Educators
    Purchase
    Related
    Chu, Michael, and V. Kasturi Rangan. "Gilead Mexico." Harvard Business School Case 318-111, March 2018. (Revised January 2019.)
    • 10 Oct 2009
    • News

    Making the 'public option' a simple one

    • 08 Jun 2020
    • News

    Tenants and Investors Will Be Looking for Healthy Buildings

    • 05 Oct 2017
    • News

    This is how gerrymandering affects US competitiveness

      Dutch Leonard

      Herman B. ("Dutch") Leonard is Eliot I. Snider and Family Professor of Business Administration at the Harvard Business School and the George F. Baker, Jr. Professor of Public Sector Management at Harvard University's John F. Kennedy School of Government. In... View Details

      Keywords: health care; health care; health care; health care; health care
      • 2025
      • Working Paper

      HIV Tests and AIDS Treatments—Containing a Fearsome Pandemic: Case Histories of Transformational Advances

      By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
      This case history describes how a diverse cast of characters, including public health organizations, research laboratories, for-profit healthcare companies, activists, and regulators, rolled back the outbreak of HIV/AIDS in just fifteen years. Moreover, as the case... View Details
      Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
      Citation
      SSRN
      Read Now
      Related
      Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "HIV Tests and AIDS Treatments—Containing a Fearsome Pandemic: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-007, July 2019. (Revised January 2025.)
      • Teaching

      Overview

      By: Regina E. Herzlinger
      Course Requirements

      Students are required to prepare a business plan, which employs the framework of this course, to explore an entrepreneurial opportunity in health care, and to evaluate their classmates' plans.

      Career Focus

      For... View Details
      • May 2020 (Revised July 2020)
      • Case

      COVID-19: The Global Shutdown

      By: Laura Alfaro and Sarah Jeong
      In the first months of 2020, a pandemic overwhelmed the world. COVID-19, commonly known as the coronavirus, spread from China and created a severe public health emergency across countries. While an immediate fear of the disease’s impact on human life permeated society,... View Details
      Keywords: Trade; Microeconomics; Macroeconomics; Financial Crisis; Economy; Economic Systems; Economic Slowdown and Stagnation; Economic Sectors; Health Pandemics
      Citation
      Educators
      Purchase
      Related
      Alfaro, Laura, and Sarah Jeong. "COVID-19: The Global Shutdown." Harvard Business School Case 320-108, May 2020. (Revised July 2020.)
      • ←
      • 19
      • 20
      • …
      • 86
      • 87
      • →
      ǁ
      Campus Map
      Harvard Business School
      Soldiers Field
      Boston, MA 02163
      →Map & Directions
      →More Contact Information
      • Make a Gift
      • Site Map
      • Jobs
      • Harvard University
      • Trademarks
      • Policies
      • Accessibility
      • Digital Accessibility
      Copyright © President & Fellows of Harvard College.